← IPO Calendar

Retension Pharmaceuticals, Inc.

RTSN

priced

Analyst-verified

Offering

View source filing

Exchange: Nasdaq
Analyst-verified
Price: $12.00
Source: Finnhub
Shares offered: 3,750,000
Source: Finnhub
Expected date: TBD
Priced date: 2026-10-09
Source: Finnhub
Industry: Biopharmaceuticals
AI-extracted
Revenue: —
Net income: —

Underwriters

Not yet disclosed.

Filings

S-1/A 2026-10-05View on EDGAR

Track RTSN

Get alerts on new filings and ask our AI analyst about this company.

Research this company

Retension Pharmaceuticals, Inc. (RTSN) IPO | PublicView